Show simple item record

dc.contributor.authorThatcher, Nick
dc.contributor.authorTaylor, P
dc.contributor.authorCarroll, K B
dc.contributor.authorLoriaux, E M
dc.contributor.authorPalmer, P
dc.contributor.authorFranks, C R
dc.date.accessioned2010-07-14T15:13:33Z
dc.date.available2010-07-14T15:13:33Z
dc.date.issued1989-06
dc.identifier.citationInterleukin-2 in malignant pleural mesothelioma (and adenocarcinoma of the lung). The use of intrapleural and continuous intravenous infusions: preliminary results. 1989, 16 Suppl A:161-2 Cancer Treat Reven
dc.identifier.issn0305-7372
dc.identifier.pmid2788503
dc.identifier.urihttp://hdl.handle.net/10541/107642
dc.language.isoenen
dc.subjectLung Canceren
dc.subjectPleural Canceren
dc.subject.meshAdenocarcinoma
dc.subject.meshDrug Administration Schedule
dc.subject.meshHumans
dc.subject.meshInfusions, Intravenous
dc.subject.meshInfusions, Parenteral
dc.subject.meshInterleukin-2
dc.subject.meshLung Neoplasms
dc.subject.meshMesothelioma
dc.subject.meshPleura
dc.subject.meshPleural Neoplasms
dc.titleInterleukin-2 in malignant pleural mesothelioma (and adenocarcinoma of the lung). The use of intrapleural and continuous intravenous infusions: preliminary results.en
dc.typeArticleen
dc.contributor.departmentChristie Hospital, Manchester, U.K.en
dc.identifier.journalCancer Treatment Reviewsen


This item appears in the following Collection(s)

Show simple item record